Contagion® to Report on MAD-ID 2019 in Orlando
Contagion® will be heading to Orlando, Florida, on Wednesday, May 8, 2019, to report on the annual Making a Difference in Infectious Diseases (MAD-ID) 2019 conference.
Contagion® will be heading to Orlando, Florida, on Wednesday, May 8, 2019, to report on the annual Making a Difference in Infectious Diseases (MAD-ID) 2019 conference, a forum that brings together pharmacists, physicians, and nurses from around the world to discuss the latest research, guidelines, and updates from the field.
As a trusted source in the realm of infectious disease, the editorial team of Contagion® strives to consistently report on new developments in the field. Some of our recent coverage includes a feature on why opioid use disorder should be thought of like an infectious disease, an update on the measles outbreaks across the United States, video coverage from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019), an article on Ebola preparedness at frontline hospitals, and a Q&A with the co-founder of the Peggy Lillis Foundation on Clostridium difficile (C diff) awareness.
Coverage of this meeting will be focused on trends in antibiotic resistance, effects of antimicrobial stewardship programs, clinical performance of novel diagnostic agents, as well as real-world drug efficacy and safety data.
Additional coverage will focus on implementing area under the curve/minimum inhibitory concentration (AUC/MIC) vancomycin dosing, as well as pharmacist impacts on antimicrobial prescribing in urgent care settings.
In keeping with our dedication to providing our readership with the most timely and relevant content to support their practices and improve patient outcomes, Contagion® editors will provide exclusive written coverage, along with engaging video interviews with several key opinion leaders on important issues and advancements made in the realm of infectious disease.
Some of the presentations that we will cover in the upcoming week include 1 from Contagion® Editor-in-Chief Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, of Temple University, who will discuss the new gram-negative agents in the antibiotic pipeline; and from Jamie Wagner, PharmD, BCPS, of the University of Mississippi School of Pharmacy, who is presenting research on classifying C diff disease severity.
We will also catch up with Contagion® section editors Monica Mahoney, PharmD, BCPS-AQ ID, BCIDP, and Ryan K. Shields, PharmD, MS, who will provide a sneak peek at the upcoming June print issue.
Thomas Lodise, PharmD, PhD, will present data on lefamulin for community acquired bacterial pneumonia, while Kieu-Nhi (Nikki) Tran, PharmD, of Sinai-Grace Hospital / Detroit Medical Center, will discuss clinical outcomes of extended infusion versus intermittent infusion for patients with gram-negative bacteremia.
Going to the conference? Be sure to say hello between interviews or sessions; we'll be there! Make sure to stop by our booth in the exhibit hall and pick up a plush microbe.
Not going to the conference? Be sure to sign up for our conference updates.